Skip to content

Blog

Author: Ashley Shanley

<a href="https://www.bioagilytix.com/blog/category/gene-therapy/">Gene Therapy</a>

Challenges for Measuring Immunogenicity of AAV-based Gene Therapies

  • September 15, 2021

Gene therapy is a powerful form of treatment that involves introducing genetic material into cells to replace defective genes resulting in the production of an…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/cell-based-assays/">Cell-Based Assays</a>

Cell-Based NAb Assays: What We Need to Know

  • September 15, 2021

Cell-Based NAb Assays So, how do we deal with NAbs when it comes to the industrial production of biotherapeutic agents? The bioanalytical community adopts a…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/gene-therapy/">Gene Therapy</a>

Cell and Gene Therapies Account for a Large Portion of the Therapeutics Market

  • March 18, 2021

Cell and gene therapies have gone through a growth spurt in the last decade. According to data from the Alliance for Regenerative Medicine (ARM), during…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Chris Carlin

  • March 12, 2021

  Tell us a little about your background and how you came to join BioAgilytix.   My first wet lab experience was gained during my…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Reema Davis

  • March 9, 2021

  Tell us a little about your background and how you came to join BioAgilytix.   I did my doctoral and postdoctoral training in Cell…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Nikhil Soni

  • March 9, 2021

Tell us a little about your background and how you came to join BioAgilytix. Some of my friends at my previous job joined BAL and…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/cmc-bioanalytical/">CMC Bioanalytical</a>

CMC Requirements for Cell and Gene Therapy for IND Applications

  • February 23, 2021

The U.S. Food and Drug Administration (FDA) has issued Chemistry, Manufacturing, and Control (CMC) recommendations for Investigational New Drug (IND) applications for human investigational gene…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/industry-update/">Industry Update</a>

FDA RACE for Children Act: What You Should Know

  • February 4, 2021

Short for Research to Accelerate Cures and Equity, the RACE Act went into effect on August 18, 2020, and significantly increased the number of required…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/cro-selection/">CRO Selection</a>

The Benefits of Outsourcing R&D Processes to CROs

  • February 2, 2021

As a leading contract research organization (CRO), BioAgilytix helps companies around the world with research and development, leveraging expertise in cell-based assays, immunogenicity, biomarkers and…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/immuno-oncology/">Immuno-oncology</a>

Noninvasive Liquid Biopsy Assays Integrating Tumor and Immune Biomarkers Prove to Be Promising Tools in Immuno-Oncology

  • January 27, 2021

Tumor tissue biopsies have been the traditional method of identifying and analyzing cancer cells. But in addition to being invasive and risky, they have many…

Find Out More